Related Experiment Video

Updated: Apr 23, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

9.7K

Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-κB

Martina Gobec1, Matevž Prijatelj1, Jozo Delić2

  • 1University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.

European Journal of Pharmacology
|September 15, 2014
PubMed

Insights

EP4 receptor agonists show promise in treating B-cell malignancies. These agonists induce apoptosis and enhance chemotherapy sensitivity in leukemia and lymphoma by downregulating NF-κB activity.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The EP4 receptor plays a role in B-cell growth inhibition via NF-κB signaling.
  • NF-κB constitutive activity is crucial for the survival of leukemia and lymphoma cells.
  • NF-κB activation is linked to multi-drug resistance in cancer.

Purpose of the Study:

  • To evaluate the EP4 receptor as a therapeutic target for B-cell malignancies.
  • To investigate the effect of EP4 receptor agonists on NF-κB signaling and apoptosis in cancer cells.
  • To assess the potential of EP4 receptor agonists in overcoming chemotherapy resistance.

Main Methods:

  • Pharmacological modulation of the EP4 receptor using a specific agonist (PGE1-OH).
  • Assessment of caspase-mediated apoptosis in malignant B cells.
  • Analysis of NF-κB activity and Bcl-xL gene expression.
  • Evaluation of chemosensitization to bortezomib and doxorubicin in Ramos cells.

Main Results:

  • EP4 receptor activation induced caspase-mediated apoptosis in malignant B cells, particularly Burkitt's lymphoma cells.
  • PGE1-OH treatment decreased NF-κB activity and Bcl-xL levels in Ramos cells.
  • EP4 receptor agonists enhanced the sensitivity of Ramos cells to bortezomib and doxorubicin.

Conclusions:

  • The EP4 receptor is a potential therapeutic target for B-cell leukemia and lymphoma.
  • EP4 receptor agonists demonstrate chemo-sensitizing properties in B-cell lymphomas.
  • Targeting NF-κB-dependent pathways with EP4 agonists offers new therapeutic strategies for B-cell malignancies.
Keywords:
ApoptosisChemosenzitationEP(4) receptorLeukemiaNF-κB

More Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.2K
Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

10.4K

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
813
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
6.8K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.0K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K